cardiovascular system
• hearts show structural abnormalities along with mitochondrial proliferation in ventricular myocardium
• hearts exhibit lipid deposition
|
• cardiomyocytes exhibit T-tubule enlargement
• however, no myocardial apoptosis, fibrosis, or inflammatory cell infiltrates are seen
|
• heart shows 11% more cardiomyocytes than controls
|
• cardiomyocytes exhibit a 23% increase in size
|
• increase in the number of cardiomyocytes and increase in size of cardiomyocytes with no loss of systolic performance, indicating compensated cardiac hypertrophy
• marker analysis indicates hypertrophic gene expression in hearts
|
• increase in left ventricle weight-to-body weight ratio by 178%
|
• increase in the thickness of the left ventricular free wall in 12 week old males
|
• echocardiography indicates that posterior wall thickness and the total left ventricular mass are increased in 12 week old males
• however, left ventricular end-systolic or end-diastolic diameters, fractional shortening, or systolic blood pressures are not altered
|
• heart rate is slightly increased in 12 week old males
|
cellular
• mitochondria are rounded and irregular in hearts
|
• mitochondria are higher in number in hearts
|
• hearts show increased activity of succinate dehydrogenase and cytochrome C oxidase and decreased adenine nucleotide translocator protein expression, indicating increased respiratory chain and oxidative phosphorylation in the mitochondria
|
• hearts show increased mitochondrial proliferation in ventricular myocardium
|
• hearts show increased activity of succinate dehydrogenase and cytochrome C oxidase and decreased adenine nucleotide translocator protein expression, indicating increased respiratory chain and oxidative phosphorylation in the mitochondria
|
muscle
• cardiomyocytes exhibit T-tubule enlargement
• however, no myocardial apoptosis, fibrosis, or inflammatory cell infiltrates are seen
|
• heart shows 11% more cardiomyocytes than controls
|
• cardiomyocytes exhibit a 23% increase in size
|
growth/size/body
• increase in the number of cardiomyocytes and increase in size of cardiomyocytes with no loss of systolic performance, indicating compensated cardiac hypertrophy
• marker analysis indicates hypertrophic gene expression in hearts
|
Mouse Models of Human Disease |
DO ID | OMIM ID(s) | Ref(s) | |
hypertrophic cardiomyopathy | DOID:11984 | J:128784 |